Skip to content

Study · Measured the body's own peptide · 1992

1 result

Mechanoluminescence: an assay for lymphocyte analysis in neoplasia.

Orel VE, Alekseyev SB, Grinevich YA

Journal of bioluminescence and chemiluminescence1 Oct 1992Cited by 5 (Europe PMC)

PMID1442175 (opens in a new tab)DOI10.1002/bio.1170070403 (opens in a new tab)PepBankPUB-01442175
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In melanoma-bearing mice after thymic-agent immunotherapy, lymphocyte light emission correlated with thymic serum factor titres, with no direction reported.

    In plain wordsIn mice with melanoma after immunotherapy, lymphocyte light emission was linked to natural thymic serum factor levels.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    Direction not reportedCorrelation of lymphocyte light emission with FTS titres
    Study

    mousen: not reported in source

    C57BL/6 mice with terminal B16 melanoma after thymic-agent immunotherapy
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    In C57BL/6 mice with B16 melanoma at the terminal stage of tumour growth and after immunotherapy with thymic agents, there is a correlation between light emission and the value of lymphocyte surface charge and titres of thymic serum factor (FTS).

    This result measures the body's own Thymulin (serum thymic factor). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.